Patents by Inventor Marcelo Arguelles

Marcelo Arguelles has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050020522
    Abstract: The present invention relates, e.g., to a method for inducing arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or for inducing mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte, comprising administering to a cell or tissue in need thereof a dose of a polynucleotide that encodes a vascular endothelial growth factor (VEGF), or that encodes a polypeptide comprising an active site of the VEGF. The coding sequence is operably linked to an expression control sequence; and the dose is sufficient to induce arteriogenesis, lymphangiogenesis, vasculogenesis, or cardiomyogenesis, and/or to induce mitosis or proliferation of a smooth muscle cell, a skeletal muscle cell, or a cardiomyocyte. In preferred embodiments of the invention, the method is a method of tissue regeneration, particularly of cardiomyogenesis; and the polynucleotide (or a polypeptide encoded by such a polynucleotde) is administered into the myocardium.
    Type: Application
    Filed: November 17, 2003
    Publication date: January 27, 2005
    Applicants: Sterrenbeld Biotechnologie North America, Inc., Fundacion Universitaria Dr. Rene G. Favaloro
    Inventors: Ruben Laguens, Marcelo Arguelles, Gustavo Leonidas Janavel, Jose Crottogini, Carlos Melo, Ricardo Pichel, Marcelo Criscuolo